Patents by Inventor Dina Fischer

Dina Fischer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8993724
    Abstract: The present invention relates to a process for the production of interferon beta, and to an interferon beta composition having a unique glycosylation pattern.
    Type: Grant
    Filed: June 14, 2011
    Date of Patent: March 31, 2015
    Assignee: Ares Trading S.A.
    Inventors: Dina Fischer, Alain Bernard, Paul Ducommun, Mara Rossi
  • Publication number: 20110305669
    Abstract: The present invention relates to a process for the production of interferon beta, and to an interferon beta composition having a unique glycosylation pattern.
    Type: Application
    Filed: June 14, 2011
    Publication date: December 15, 2011
    Applicant: ARES TRADING S.A.
    Inventors: DINA FISCHER, Alain Bernard, Paul Ducommun, Mara Rossi
  • Publication number: 20080219952
    Abstract: The present invention relates to a process for the production of interferon beta, and to an interferon beta composition having a unique glycosylation pattern.
    Type: Application
    Filed: August 26, 2005
    Publication date: September 11, 2008
    Applicant: ARES TRADING S.A.
    Inventors: Dina Fischer, Alain Bernard, Paul Ducommun, Mara Rossi
  • Patent number: 5641647
    Abstract: A serum free medium capable of supporting production of mammalian cell products is provided. The medium comprises a basic medium and a cell viability protection agent, insulin and thrombin or a thrombin receptor activator.
    Type: Grant
    Filed: August 24, 1993
    Date of Patent: June 24, 1997
    Assignee: Interpharm Laboratories Ltd.
    Inventors: Dina Fischer, Moshe Bracha
  • Patent number: 4897264
    Abstract: Analysis of [.sup.125 I]. interferon gamma cross-linked to its receptor on various human cells by SDS-PAGE revealed that there are at least three different types of human interferon gamma receptors. In WISH, HeLa, FS11 and the other tissue cells an Mr 90,000-105,000 receptor was found. In monocytes and in the myeloid cell line KG-1 an Mr 140,000 receptor was found while in Daudi lymphoblastoid cells an Mr 95,000-115,000 receptor was found.The various receptors were isolated from these cells by extraction followed by affinity chromotography on an immobilized interferon gamma column. The resulting purified preparations retained their original affinity for interferon gamma and were used for immunizing mice and subsequent development of highly specific antibodies.
    Type: Grant
    Filed: March 27, 1987
    Date of Patent: January 30, 1990
    Assignee: Yeda Research and Development Co., Ltd.
    Inventors: Daniela Novick, Patricia Orchansky, Dina Fischer, Menachem Rubinstein
  • Patent number: 4617378
    Abstract: There is provided a process for purification of human immune interferon (IFN-.gamma.) to homogeneity without appreciable loss of biological activity by the use of chromatography on controlled-pore glass, ultrafiltration and high performance cation exchange chromatography, resulting in essentially pure human interferon subtypes 21K and 26K, and there are provided said purified interferons and pharmaceutical compositions containing same.
    Type: Grant
    Filed: January 18, 1984
    Date of Patent: October 14, 1986
    Assignee: Yeda Research and Development Co., Ltd.
    Inventors: Menachem Rubinstein, Jossef Friedlander, Dina Fischer